Jiuyuan Yinhai(002777) 东方财富证券·2024-06-07 10:30Investment Rating - The report maintains a "Buy" rating for the company with a 12-month target price of 17.9 yuan [70][76] Core Views - The company is a leading smart livelihood service provider in China, focusing on three strategic directions: medical and healthcare, digital government, and smart cities [95][97] - The company has a stable equity structure, with the Chinese Academy of Engineering Physics as the actual controller, holding 38.31% of the shares [120] - The company's revenue and net profit have shown a recovery trend, with 2023 revenue reaching 1.347 billion yuan, a year-on-year increase of 5.01%, and net profit of 168 million yuan [124] - The company's main revenue sources are medical and healthcare, and smart city and digital government businesses, accounting for over 90% of total revenue [6] - The company has a leading position in the medical and healthcare informationization market, with its market share ranking second in the domestic medical insurance IT market [16][80] Business Segments Medical and Healthcare - The company's medical and healthcare business covers 23 provinces, serving over 160,000 medical insurance institutions, and has a leading position in the DRG/DIP payment reform market [80][142] - The company's medical health business covers 20 provinces and over 2,800 hospitals, providing solutions for high-quality hospital development [80] - The company is actively involved in the construction of medical consortia, providing integrated solutions for smart hospitals, smart medical consortia, and internet healthcare [53][142] - The company is a pioneer in medical insurance data elements, actively building data zones and optimizing data governance in Sichuan and Yunnan provinces [32][80] Digital Government and Smart Cities - The company's digital government business includes human resources and social security, housing finance, civil affairs, market supervision, and other areas, covering 21 provinces [97] - The company's smart city business focuses on building city-level core platforms, participating in the construction of "Digital Chongqing" and "Smart Rongcheng" [111] - In 2023, the company's smart city and digital government business revenue was 618 million yuan, and it is expected to grow to 668 million yuan, 748 million yuan, and 834 million yuan in 2024-2026 [44][111] Industry Trends - The medical and healthcare informationization market is expanding, with the domestic medical IT market expected to reach 35.75 billion yuan by 2028, and the medical insurance IT market expected to reach 8.15 billion yuan [80][157] - The DRG/DIP payment reform is driving market growth, with the overall market size expected to reach 18.174 billion yuan by 2024 [80] - The construction of medical consortia is accelerating, with the goal of achieving full coverage of tightly-knit county medical consortia by 2027 [26][142] - The medical insurance data element market is expected to grow rapidly, with the medical big data solutions market expected to reach 57.7 billion yuan by 2024 [57][149] Financial Performance - The company's revenue in 2023 was 1.347 billion yuan, a year-on-year increase of 5.01%, and net profit was 168 million yuan [124] - The company's gross profit margin has been under pressure due to economic conditions, dropping to 47.6% in 2023, but the gross profit margin of the smart city and digital government business has increased to 54.4% [125][126] - The company's R&D investment in 2023 was 152 million yuan, with an R&D expense ratio of 11.31% [8] - The company's operating cash flow in 2023 was 188.38 million yuan, and net profit was 178.73 million yuan [48]